Lista de obras - Jack T Rogers - Dominio Público Uruguay

A high-throughput drug screen targeted to the 5'untranslated region of Alzheimer amyloid precursor protein mRNA.

artículo científico publicado en 2006

A review of independent component analysis application to microarray gene expression data

artículo científico publicado en 2008

A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity.

artículo científico publicado en 2016

Alzheimer's disease drug discovery targeted to the APP mRNA 5'untranslated region

artículo científico publicado en 2002

Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis

artículo científico publicado en 2014

An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript

artículo científico publicado en 2002

Assessments of plasma ghrelin levels in the early stages of parkinson's disease.

artículo científico publicado en 2017

Brain Iron Metabolism Dysfunction in Parkinson's Disease.

artículo científico publicado en 2016

Differential Expression of the Activator Protein 1 Transcription Factor Regulates Interleukin-1ß Induction of Interleukin 6 in the Developing Enterocyte

artículo científico publicado en 2016

Drug Discovery Targeted to the Alzheimer's APP mRNA 5'-Untranslated Region: The Action of Paroxetine and Dimercaptopropanol ⬇️

artículo científico publicado el 1 de enero de 2003

Independent component analysis of Alzheimer's DNA microarray gene expression data

artículo científico publicado en 2009

Interleukin-1alpha stimulates non-amyloidogenic pathway by alpha-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase.

artículo científico publicado en 2006

Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease

artículo científico publicado en 2008

Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease

artículo científico publicado en 2010

L-arginine and Alzheimer's disease.

artículo científico publicado en 2008

Metal exposure and Alzheimer's pathogenesis.

artículo científico publicado en 2006

N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease

artículo científico publicado en 2012

Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease

artículo científico publicado en 2013

Novel drug targets based on metallobiology of Alzheimer's disease.

artículo científico publicado en 2010

Parkinson's disease iron deposition caused by nitric oxide-induced loss of β-amyloid precursor protein.

artículo científico publicado en 2015

Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element

artículo científico publicado en 2009

Pilot study of the reducing effect on amyloidosis in vivo by three FDA pre-approved drugs via the Alzheimer's APP 5' untranslated region

artículo científico publicado en 2005

Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis

artículo científico publicado en 2004

RNA therapeutics directed to the non coding regions of APP mRNA, in vivo anti-amyloid efficacy of paroxetine, erythromycin, and N-acetyl cysteine

artículo científico publicado en 2006

Redox-active metals, oxidative stress, and Alzheimer's disease pathology

artículo científico publicado en 2004

Role of cytokines in the gene expression of amyloid β–protein precursor: Identification of a 5'-UTR-Binding nuclear factor and its implications in Alzheimer's disease ⬇️

artículo científico publicado el 1 de abril de 2003

S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life.

artículo científico publicado en 2018

The Anticholinesterase Phenserine and Its Enantiomer Posiphen as 5′Untranslated-Region-Directed Translation Blockers of the Parkinson’s Alpha Synuclein Expression ⬇️

artículo científico publicado el 29 de mayo de 2012

The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen

artículo científico publicado en 2011

The role of T cells in osteoporosis, an update.

artículo científico publicado en 2009

Lista de obras de Jack T Rogers

A high-throughput drug screen targeted to the 5'untranslated region of Alzheimer amyloid precursor protein mRNA.

A review of independent component analysis application to microarray gene expression data

A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity.

Alzheimer's disease drug discovery targeted to the APP mRNA 5'untranslated region

Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis

An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript

Assessments of plasma ghrelin levels in the early stages of parkinson's disease.

Brain Iron Metabolism Dysfunction in Parkinson's Disease.

Differential Expression of the Activator Protein 1 Transcription Factor Regulates Interleukin-1ß Induction of Interleukin 6 in the Developing Enterocyte

Drug Discovery Targeted to the Alzheimer's APP mRNA 5'-Untranslated Region: The Action of Paroxetine and Dimercaptopropanol ⬇️

Independent component analysis of Alzheimer's DNA microarray gene expression data

Interleukin-1alpha stimulates non-amyloidogenic pathway by alpha-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase.

Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease

Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease

L-arginine and Alzheimer's disease.

Metal exposure and Alzheimer's pathogenesis.

N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease

Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease

Novel drug targets based on metallobiology of Alzheimer's disease.

Parkinson's disease iron deposition caused by nitric oxide-induced loss of β-amyloid precursor protein.

Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element

Pilot study of the reducing effect on amyloidosis in vivo by three FDA pre-approved drugs via the Alzheimer's APP 5' untranslated region

Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis

RNA therapeutics directed to the non coding regions of APP mRNA, in vivo anti-amyloid efficacy of paroxetine, erythromycin, and N-acetyl cysteine

Redox-active metals, oxidative stress, and Alzheimer's disease pathology

Role of cytokines in the gene expression of amyloid β–protein precursor: Identification of a 5'-UTR-Binding nuclear factor and its implications in Alzheimer's disease ⬇️

S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life.

The Anticholinesterase Phenserine and Its Enantiomer Posiphen as 5′Untranslated-Region-Directed Translation Blockers of the Parkinson’s Alpha Synuclein Expression ⬇️

The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen

The role of T cells in osteoporosis, an update.